X4 Pharmaceuticals

XFOR

Börsenwert 325 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 NEA Management Company Timonium, Maryland	5,8 Mio. $	–	–	–
2	2 OrbiMed New York	5,42 Mio. $	–	–	–
3	3 Polaris Venture Management Co V Boston, Massachusetts	5,42 Mio. $	–	–	–
4	4 SV Health Investors Boston, Massachusetts	5,42 Mio. $	–	–	–
5	5 Cormorant Asset Management Boston, Massachusetts	4,4 Mio. $	-1,06 Mio. $	-1.918	-19 %
6	6 Vanguard Group Malvern, Pennsylvania	1,5 Mio. $	+611.485 $	+1.108	+63 %
7	7 Federated Hermes Pittsburgh, Pennsylvania	1,19 Mio. $	–	–	–
8	8 BlackRock New York	694.000 $	-45.806 $	-83	-6 %
9	9 First Eagle Investment Management New York	361.000 $	–	–	–
10	10 State Street Boston, Massachusetts	308.000 $	-2.759 $	-5	-0,8 %
11	11 Geode Capital Management Boston, Massachusetts	224.000 $	+34.769 $	+63	+17 %
12	12 TIAA CREF Investment Management New York	174.000 $	+113.136 $	+205	+160 %
13	13 Deutsche Bank Frankfurt Am Main Ge, Germany	69.000 $	+54.636 $	+99	+275 %
14	14 Bank of America Charlotte, North Carolina	37.000 $	+29.250 $	+53	+294 %
15	15 California State Teachers Retirement System (CalSTRS) West Sacramento, California	21.000 $	–	–	–
16	16 New York State Common Retirement Fund Albany, New York	14.000 $	–	–	–
17	17 American International Group New York	10.000 $	-552 $	-1	-5 %
18	18 Morgan Stanley New York	8.000 $	-22.627 $	-41	-72 %
19	19 Wells Fargo San Francisco, California	8.000 $	–	–	–
20	20 Tower Research Capital (TRC) New York	8.000 $	+8.278 $	+15	Neu
21	21 Meeder Asset Management Dublin, Ohio	7.000 $	+2.759 $	+5	+63 %
22	22 Citigroup New York	6.000 $	+2.759 $	+5	+63 %
23	23 Cable Hill Partners Portland, Oregon	5.000 $	+4.415 $	+8	+800 %
24	24 JP Morgan Chase New York	4.000 $	-1.656 $	-3	-30 %
25	25 Barclays London, United Kingdom	4.000 $	+4.415 $	+8	Neu

X4 Pharmaceuticals XFOR Börsenwert 325 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 325 Mio. $